STOCK TITAN

If You Invested in Vynleads Inc (VYND)

Healthcare · Health Information Services · OTC
See the VYND overview
VYND has not traded since Jun 25, 2026. Its last close was $0.4098, so every figure on this page ends there and the 1, 5 and 10 year results count back from that close.
$1,000 invested 1 Year Before Its Last Close
N/A
Comparable prices start Jun 12, 2026
$1,000 invested 5 Years Before Its Last Close
N/A
Comparable prices start Jun 12, 2026
$1,000 invested 10 Years Before Its Last Close
N/A
Comparable prices start Jun 12, 2026

What $1,000 or $10,000 in VYND Was Worth at Its Last Close

Real historical value by amount invested and how long before the last close
If you invested 1 year before 5 years before 10 years before Since Jun 12, 2026
$1,000 — — — $836 -16%
$10,000 — — — $8,363 -16%

Based on real historical closing prices adjusted for stock splits, without dividends, through the latest market close. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results. We start VYND on Jun 12, 2026 because the prices we hold from before that date cannot be compared with the later ones, and a return measured across the two would be wrong.

Custom Calculation

Choose your own date and amount for VYND

$1,000 Investment Over Time

VYND vs S&P 500

Year-by-Year Returns

VYND annual performance
Year Start Price End Price Annual Return Cumulative
2026Jun 12, 2026 to Jun 25, 2026 $0.49 $0.4098 -16.4% -16.4%

About Vynleads Inc

Healthcare · OTC

Vynleads Inc. develops technology-enabled wellness programs for chronic, lifestyle-driven conditions. The company trades on the OTCQB under the symbol VYND and is building a consumer wellness platform that translates lifestyle medicine principles into structured daily routines. Its work centers on condition-aware programs that combine digital guidance, AI-powered coaching, community support, and habit formation tools for users managing metabolic health goals.

The company’s flagship program is Done With Diabetes™, a mobile-first digital wellness app designed for adults with type 2 diabetes, prediabetes, and related metabolic health objectives. The app organizes behavior change around an 8-week Success Blueprint and adds ongoing support through the Dr. Smith AI Wellness Coach, AI Agent-powered community features, gamification, and an AI-powered Lifetime Wellness Mode. The platform is designed to provide repeatable daily structure outside the clinical setting, where food choices, movement, consistency, and lifestyle habits affect metabolic wellness.

Vynleads has described Done With (DWX) as its broader Lifestyle Blueprint technology platform. DWX is intended to support condition-specific wellness programs that convert evidence-informed guidance into routines consumers can follow over time. Done With Diabetes serves as the foundation for that platform, with the company positioning the model for additional health domains where chronic conditions are influenced by habits and daily adherence.

The company’s commercial model includes subscriptions to the Done With Diabetes app. This structure links Vynleads’ wellness content, AI coaching, and community engagement features to a recurring consumer software model rather than a one-time product sale. The company’s public profile is therefore centered on digital health, metabolic wellness, lifestyle medicine, AI-enabled coaching, and condition-specific consumer wellness programs.

Last Close
$0.4098
EPS (FY2025)
-$0.01
Revenue (FY2025)
$0.0B
View full VYND overview

Frequently Asked Questions

Vynleads Inc investment returns

How much was $1,000 invested in Vynleads Inc worth at its last close?

Limited historical data is available for VYND. The prices we can compare start on 2026-06-12.

Has Vynleads Inc outperformed the S&P 500?

Comparison data requires at least 10 years of trading history. Use the calculator above to compare VYND performance over available time periods.

For informational and educational purposes only, not investment advice.